Biodesix Biodesix Q2 Revenues Shoot up but Fall Short of Wall Street Expectations COVID-19 testing revenues grew to $6.0 million while lung diagnostic revenues rose to $4.8 million and biopharma revenues increased to $1.0 million. Biodesix, Datavant Join in Lung Cancer Data Partnership Datavant will anonymize lung cancer records from the Biodesix biobank and add real-world data to aid researchers and biopharma companies. Biodesix Q1 Revenues Soar on COVID-19 Testing For the three months ended March 31, the firm reported revenues of $28.9 million, compared to $5.1 million in the same period a year ago. Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market Premium The firm will commercialize its Primary Immune Response assay as a laboratory-developed test to help guide immunotherapy decisions in lung cancer patients. Biodesix Secures $30M Term Loan The firm used the proceeds to repay outstanding borrowings of $25.9 million under its existing loan with Innovatus Life Sciences Lending Fund. Mar 16, 2021 Biodesix Q4 Revenues More Than Triple on COVID-19 Testing Jan 8, 2021 Biodesix Preliminary Q4 Revenues Up Over 200 Percent Dec 11, 2020 Biodesix Q3 Revenues Rise Sharply Nov 23, 2020 Three Investment Banks Initiate Coverage of Biodesix Oct 28, 2020 Biodesix Prices $72M IPO Oct 1, 2020 Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance Aug 17, 2020 Biodesix Turns to Digital PCR to Maintain Round-The-Clock COVID Testing Premium Mar 20, 2020 Biodesix, Bio-Rad Partner on Coronavirus Test Jan 29, 2020 Biodesix, Streck Partner on Cancer CDx Sample Collection Nov 8, 2019 People in the News: Roland Diggelmann, Victor Esch, Scott Hutton, David Brunel, More Jul 29, 2019 Biodesix, Immodulon Collaborating on Pancreatic Cancer Biomarkers Jul 9, 2019 Biodesix to Develop Blood-Based Lung Cancer Diagnostic Using Thermo Sequencing Panel Jan 28, 2019 Biodesix, MRM Proteomics Partner on Lung Cancer Assays Jul 10, 2018 Biodesix Buy Provides Commercial Path Forward for Indi XL2 Lung Nodule Test Premium Jul 9, 2018 Biodesix Acquires Integrated Diagnostics Mar 5, 2018 Biodesix Inks $23M Debt Refinancing Jan 31, 2018 Biodesix, University of Colorado Partner on Lung Cancer Assay Dec 14, 2017 Biodesix Putting Focus on Veristrat's Prognostic Capabilities Premium Nov 17, 2017 Biodesix Pushes Back Immunotherapy Test Development Timeline Premium Jun 20, 2017 Biodesix Receives NY State Approval for GeneStrat Test Load More Breaking News Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More FDA Grants Emergency Use Authorization for Northeastern University SARS-CoV-2 Test The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.